- Report
- October 2024
- 185 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- September 2024
- 100 Pages
Global
From €5559EUR$5,950USD£4,702GBP
- Report
- March 2024
- 200 Pages
Global
From €3877EUR$4,150USD£3,280GBP
- Report
- April 2023
- 111 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- August 2022
- 120 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- December 2023
- 100 Pages
Africa
From €1868EUR$2,000USD£1,581GBP
- Report
- December 2023
- 180 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- December 2023
- 80 Pages
United States
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
India
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
Germany
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
France
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
China
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1401EUR$1,500USD£1,185GBP
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
Poland
From €1401EUR$1,500USD£1,185GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1401EUR$1,500USD£1,185GBP
- Report
- March 2024
- 90 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- September 2022
- 78 Pages
Global
From €3500EUR$4,013USD£3,065GBP

Artesunate is an antimalarial drug used to treat severe malaria. It is a semi-synthetic derivative of the naturally occurring sesquiterpene lactone artemisinin, which is extracted from the plant Artemisia annua. Artesunate is used in combination with other antimalarial drugs to treat severe malaria, as it is more effective than monotherapy. It is also used to treat uncomplicated malaria, as it is more effective than other antimalarial drugs. Artesunate is available in both oral and injectable forms, and is used in combination with other antimalarial drugs to treat severe malaria.
The artesunate market is a rapidly growing market, driven by the increasing prevalence of malaria and the need for effective treatments. The market is expected to grow at a steady rate in the coming years, as the demand for antimalarial drugs increases.
Some of the major companies in the artesunate market include Sanofi, GlaxoSmithKline, Novartis, Pfizer, Merck, and Cipla. Show Less Read more